- Home
- PRQR vs FINW Comparison
PRQR vs FINW Comparison
Compare PRQR & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- FINW
- Stock Information
- Founded
- PRQR 2012
- FINW 1999
- Country
- PRQR Netherlands
- FINW United States
- Employees
- PRQR N/A
- FINW N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- FINW Commercial Banks
- Sector
- PRQR Health Care
- FINW Finance
- Exchange
- PRQR Nasdaq
- FINW Nasdaq
- Market Cap
- PRQR 179.1M
- FINW 196.2M
- IPO Year
- PRQR 2014
- FINW 2021
- Fundamental
- Price
- PRQR $2.30
- FINW $15.92
- Analyst Decision
- PRQR Strong Buy
- FINW Buy
- Analyst Count
- PRQR 8
- FINW 4
- Target Price
- PRQR $8.88
- FINW $20.75
- AVG Volume (30 Days)
- PRQR 362.3K
- FINW 77.7K
- Earning Date
- PRQR 08-07-2025
- FINW 07-24-2025
- Dividend Yield
- PRQR N/A
- FINW N/A
- EPS Growth
- PRQR N/A
- FINW N/A
- EPS
- PRQR N/A
- FINW 0.91
- Revenue
- PRQR $21,212,711.00
- FINW $72,056,000.00
- Revenue This Year
- PRQR N/A
- FINW $38.17
- Revenue Next Year
- PRQR N/A
- FINW $18.44
- P/E Ratio
- PRQR N/A
- FINW $17.41
- Revenue Growth
- PRQR 85.91
- FINW 7.66
- 52 Week Low
- PRQR $1.07
- FINW $10.29
- 52 Week High
- PRQR $4.62
- FINW $20.94
- Technical
- Relative Strength Index (RSI)
- PRQR 68.07
- FINW 71.92
- Support Level
- PRQR $2.10
- FINW $15.23
- Resistance Level
- PRQR $2.18
- FINW $14.37
- Average True Range (ATR)
- PRQR 0.13
- FINW 0.56
- MACD
- PRQR 0.01
- FINW 0.23
- Stochastic Oscillator
- PRQR 54.55
- FINW 100.00
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.